Sinovac Biotech Analyst Price Targets - Benzinga

SPY761.26−0.26%QQQ707.87−0.27%BTC/USD—DIA518.00−0.21%GLD381.40−0.16%TLT80.06+0.01%

Sinovac Biotech Ltd

SVANASDAQ

Trade with Public

Trade with Public

$5.85

Overview News Earnings Forecast EventsPrice TargetsFinancials Sentiment Compare Stock Report

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2026 Benzinga | All Rights Reserved

Sinovac Biotech Analyst Price Targets

Wall Street analyst price targets and consensus rating for Sinovac Biotech (SVA).

Price Target Range — 1 Quarters

Analyst Consensus — 1 Analysts

1Buy

Consensus RatingBuy# Analysts1Avg. Consensus PT$1Upside to Avg. PT-82.9%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 8, 2026	HC Wainwright & Co.	Joseph Pantginis	PT Cut	Buy	$6→$1

Analyst Ratings News

Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023

Benzinga Insights

Benzinga's Top Ratings Upgrades, Downgrades For July 5, 2022

Benzinga Insights

18 Biggest Mid-Day Gainers For Monday

Benzinga

Report On Sinovac From Geoinvesting, Says Court Docs Show CEO Bribed Chinese FDA, Buyout Could Be Jeopardized

Benzinga

Watch Stocks of Co.'s with Flu-Related Solutions; Macquarie Note Earlier Highlighted 'Early Flu Results Lagging

Benzinga

UPDATE: Morgan Stanley Reiterates On Sinovac Biotech Ltd. Following Solid 1Q14 EPS

Benzinga